Chinese-produced New Drugs Approved for Marketing in 2018

Recombinant Cytokine Gene Derived Protein Injection

Novaferon

Biological product for treatment 1

Genova Inc.

Apr. 20, 2018

HBV

Anlotinib Hydrochloride Capsules

FOCUS V

Chemical drug 1

Chiatai Tianqing

May 17, 2018

Locally advanced or metastatic NSCLC

Mecapegfilgrastim Injection

Aiduo

Biological product for treatment 9

Hengrui Medicine

May 17, 2018

Neutropenia

Albuvirtide for Injection

Aikening

Chemical drug 1

Frontier Biotechnologies

May 30, 2018

HIV-1

Danoprevir Sodium Tablets

Ganovo

Chemical drug 1

Ascletis

June 15, 2018

HCV

Pegylated Recombinant Interferon Variant Injection

Kailiwei

Biological product for treatment 9

Beijing Kawin

July 6, 2018

HCV

Pyrotinib Maleate Tablets

Airuini

Chemical drug 1

Hengrui Medicine

Aug. 17, 2018

Human epidermal growth factor receptor 2 (HER2)-positive advanced breast cancer

Fruquintinib Capsules

Elunate

Chemical drug 1

Hutchison MediPharma

Sep. 13, 2018    

Colorectal cancer

Toripalimab Injection

Tuoyi

Biological product for treatment 1

Junshi Biosciences

Dec. 21, 2018

Melanoma

Sintilimab Injection

Tyvyt

Biological product for treatment 1

Innovent

Dec. 27, 2018

Classical Hodgkin's lymphoma

Jinrong Xiaopi Granules

/

TCM 6.1

Kangyuan Pharmaceutical

Dec. 27, 2018

Cyclomastopathy: intermingled phlegm and blood stasis and disharmony of the thoroughfare and conception vessels